You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Evidence-Based Dermatology: Original Contributions What Proportion of Dermatological Patients Receive Evidence-Based Treatment?
Damiano Abeni; Carlo René Girardelli; Cinzia Masini; Rossella Aprea; Carmelo Franco Melchi; Pietro Puddu; Paolo Pasquini
Arch Dermatol 2001; 137: 771-776.
[Abstract][Full text][PDF]
Studies Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma
Madeleine Duvic; Ann G. Martin; Youn Kim; Elise Olsen; Gary S. Wood; Constance A. Crowley; Richard C. Yocum; for the Worldwide Bexarotene Study Group
Arch Dermatol 2001; 137: 581-593.
[Abstract][Full text][PDF]
Editorials A New Rexinoid for Cutaneous T-Cell Lymphoma